Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 6830-6838

  Seung, Edward ^a   Cho, Josalyn L ^a   Sparwasser, Tim ^b   Medoff, Benjamin D ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL TRANSPORT; CONTROLLED STUDY; EFFECTOR CELL; GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY T LYMPHOCYTE; RISK REDUCTION; SURVIVAL RATE; TRANSPLANTATION TOLERANCE; WILD TYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; GRAFT REJECTION; INFLAMMATION; LUNG TRANSPLANTATION; MICE; RECEPTORS, CXCR3; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 79959558495     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001049     Document Type: Article

References (66)

1. Trulock, E. P. 2001. Lung and heart-lung transplantation: overview of results. Semin. Respir. Crit. Care Med. 22: 479-488.
2. DeMeo, D. L., and L. C. Ginns. 2001. Clinical status of lung transplantation. Transplantation 72: 1713-1724.
3. Hertz, M. I., P. Aurora, J. D. Christie, F. Dobbels, L. B. Edwards, R. Kirk, A. Y. Kucheryavaya, A. O. Rahmel, A. W. Rowe, and D. O. Taylor. 2008. Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J. Heart Lung Transplant. 27: 937-942.
4. Heng, D., L. D. Sharples, K. McNeil, S. Stewart, T. Wreghitt, and J. Wallwork. 1998. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J. Heart Lung Transplant. 17: 1255-1263. (Pubitemid 29013408)
5. Stewart, K. C., and G. A. Patterson. 2001. Current trends in lung transplantation. Am. J. Transplant. 1: 204-210.
6. Trulock, E. P. 1997. Lung transplantation. Am. J. Respir. Crit. Care Med. 155: 789-818.
7. Kingsley, C. I., S. N. Nadig, and K. J. Wood. 2007. Transplantation tolerance: lessons from experimental rodent models. Transpl. Int. 20: 828-841.
8. Lechler, R. I., M. Sykes, A. W. Thomson, and L. A. Turka. 2005. Organ transplantation - how much of the promise has been realized? Nat. Med. 11: 605-613.
9. Li, X. C., T. B. Strom, L. A. Turka, and A. D. Wells. 2001. T cell death and transplantation tolerance. Immunity 14: 407-416.
10. Long, E., and K. J. Wood. 2009. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation 88: 1050-1056.
11. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
12. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4: 337-342.
13. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
14. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
15. Sánchez-Fueyo, A., M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168: 2274-2281.
16. Taylor, P. A., R. J. Noelle, and B. R. Blazar. 2001. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193: 1311-1318.
17. Zheng, X. X., A. Sanchez-Fueyo, C. Domenig, and T. B. Strom. 2003. The balance of deletion and regulation in allograft tolerance. Immunol. Rev. 196: 75-84.
18. Starzl, T. E., N. Murase, K. Abu-Elmagd, E. A. Gray, R. Shapiro, B. Eghtesad, R. J. Corry, M. L. Jordan, P. Fontes, T. Gayowski, et al. 2003. Tolerogenic immunosuppression for organ transplantation. Lancet 361: 1502-1510. (Pubitemid 36566340)
19. Claas, F. H. 2003. Towards clinical transplantation tolerance. Lancet 361: 1489-1490. (Pubitemid 36566336)
20. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch, III, D. A. Zisman, Y. Y. Xue, K. Li, A. Ardehali, D. J. Ross, and R. M. Strieter. 2003. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J. Immunol. 171: 4844-4852.
21. Medoff, B. D., E. Seung, J. C. Wain, T. K. Means, G. S. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al. 2005. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202: 97-110.
22. Rabinowich, H., A. Zeevi, I. L. Paradis, S. A. Yousem, J. H. Dauber, R. Kormos, R. L. Hardesty, B. P. Griffith, and R. J. Duquesnoy. 1990. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 49: 115-121.
23. Luster, A. D. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
24. Luster, A. D., R. Alon, and U. H. von Andrian. 2005. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6: 1182-1190.
25. Luster, A. D., and A. M. Tager. 2004. T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4: 711-724.
26. Medoff, B. D., S. Y. Thomas, and A. D. Luster. 2008. T cell trafficking in allergic asthma: the ins and outs. Annu. Rev. Immunol. 26: 205-232.
27. el-Sawy, T., N. M. Fahmy, and R. L. Fairchild. 2002. Chemokines: directing leukocyte infiltration into allografts. Curr. Opin. Immunol. 14: 562-568.
28. Agostini, C., F. Calabrese, F. Rea, M. Facco, A. Tosoni, M. Loy, G. Binotto, M. Valente, L. Trentin, and G. Semenzato. 2001. Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am. J. Pathol. 158: 1703-1711.
29. Hancock, W. W. 2003. Chemokine receptor-dependent alloresponses. Immunol. Rev. 196: 37-50.
30. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
31. Zhang, Z., L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer. 2002. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism. J. Immunol. 168: 3205-3212. (Pubitemid 34250379)
32. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
33. Miura, M., K. Morita, H. Kobayashi, T. A. Hamilton, M. D. Burdick, R. M. Strieter, and R. L. Fairchild. 2001. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J. Immunol. 167: 3494-3504.
34. Medoff, B. D., J. C. Wain, E. Seung, R. Jackobek, T. K. Means, L. C. Ginns, J. M. Farber, and A. D. Luster. 2006. CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function. J. Immunol. 176: 7087-7095.
35. -/- mouse recipients. Am. J. Transplant. 8: 1593-1603.
36. Zerwes, H. G., J. Li, J. Kovarik, M. Streiff, M. Hofmann, L. Roth, M. Luyten, C. Pally, R. P. Loewe, G. Wieczorek, et al. 2008. The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats. Am. J. Transplant. 8: 1604-1613.
37. Thomas, S. Y., R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, and A. D. Luster. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171: 2571-2580.
38. Eksteen, B., A. Miles, S. M. Curbishley, C. Tselepis, A. J. Grant, L. S. Walker, and D. H. Adams. 2006. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. J. Immunol. 177: 593-603.
39. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, F. Brière, G. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
40. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H.Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57-63.
41. Grabie, N., M. W. Delfs, J. R. Westrich, V. A. Love, G. Stavrakis, F. Ahmad, C. E. Seidman, J. G. Seidman, and A. H. Lichtman. 2003. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J. Clin. Invest. 111: 671-680.
42. Medoff, B. D., A. Sauty, A. M. Tager, J. A. Maclean, R. N. Smith, A. Mathew, J. H. Dufour, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168: 5278-5286.
43. Belperio, J. A., M. P. Keane, M. D. Burdick, J. P. Lynch, III, Y. Y. Xue, K. Li, D. J. Ross, and R. M. Strieter. 2002. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J. Immunol. 169: 1037-1049.
44. Campanella, G. S., B. D. Medoff, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Development of a novel chemokine-mediated in vivo T cell recruitment assay. J. Immunol. Methods 331: 127-139.
45. Salomon, B., D. J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J. A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
46. Nelson, P. J., and A. M. Krensky. 2001. Chemokines, chemokine receptors, and allograft rejection. Immunity 14: 377-386.
47. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707.
48. Hänninen, A., R. Nurmela, M. Maksimow, J. Heino, S. Jalkanen, and C. Kurts. 2007. Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am. J. Pathol. 170: 240-250.
49. Melter, M., A. Exeni, M. E. J. Reinders, J. C. Fang, G. McMahon, P. Ganz, W. W. Hancock, and D. M. Briscoe. 2001. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104: 2558-2564.
50. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
51. Uppaluri, R., K. C. Sheehan, L. Wang, J. D. Bui, J. J. Brotman, B. Lu, C. Gerard, W. W. Hancock, and R. D. Schreiber. 2008. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 86: 137-147.
52. Thomas, S. Y., A. Banerji, B. D. Medoff, C. M. Lilly, and A. D. Luster. 2007. Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J. Immunol. 179: 1901-1912.
53. Sauty, A., R. A. Colvin, L. Wagner, S. Rochat, F. Spertini, and A. D. Luster. 2001. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J. Immunol. 167: 7084-7093.
54. Menning, A., U. E. Höpken, K. Siegmund, M. Lipp, A. Hamann, and J. Huehn. 2007. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur. J. Immunol. 37: 1575-1583.
55. Schnickel, G. T., S. Bastani, G. R. Hsieh, A. Shefizadeh, R. Bhatia, M. C. Fishbein, J. Belperio, and A. Ardehali. 2008. Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection. J. Immunol. 180: 4714-4721.
56. Kang, S. M., Q. Tang, and J. A. Bluestone. 2007. CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am. J. Transplant. 7: 1457-1463.
57. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7: 875-888.
58. McLachlan, J. B., D. M. Catron, J. J. Moon, and M. K. Jenkins. 2009. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 30: 277-288.
59. Walsh, P. T., D. K. Taylor, and L. A. Turka. 2004. Tregs and transplantation tolerance. J. Clin. Invest. 114: 1398-1403.
60. Thornton, A. M., E. E. Donovan, C. A. Piccirillo, and E. M. Shevach. 2004. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25 + T cell suppressor function. J. Immunol. 172: 6519-6523.
61. Josefowicz, S. Z., and A. Rudensky. 2009. Control of regulatory T cell lineage commitment and maintenance. Immunity 30: 616-625.
62. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178.
63. Chappert, P., M. Leboeuf, P. Rameau, M. Lalfer, S. Desbois, R. S. Liblau, O. Danos, J. M. Davoust, and D. A. Gross. 2010. Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion. Eur. J. Immunol. 40: 339-350.
64. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
65. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
66. Oldenhove, G., N. Bouladoux, E. A. Wohlfert, J. A. Hall, D. Chou, L. Dos Santos, S. O'Brien, R. Blank, E. Lamb, S. Natarajan, et al. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772-786.